Edition:
India

Revance Therapeutics Inc (RVNC.OQ)

RVNC.OQ on NASDAQ Stock Exchange Global Market

15.72USD
18 Mar 2019
Change (% chg)

$0.27 (+1.75%)
Prev Close
$15.45
Open
$15.48
Day's High
$15.72
Day's Low
$15.10
Volume
38,584
Avg. Vol
137,097
52-wk High
$34.20
52-wk Low
$15.10

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.90 December 18 Mar 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 2 2
(2) OUTPERFORM 6 7 7 7
(3) HOLD 2 2 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.91 1.92 1.90 1.90

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 9 1.84 5.50 0.50 0.09
Quarter Ending Jun-19 9 1.83 5.50 0.50 0.09
Year Ending Dec-19 10 6.50 22.00 0.30 0.56
Year Ending Dec-20 10 40.97 66.71 22.84 56.26
Earnings (per share)
Quarter Ending Mar-19 9 -0.90 -0.77 -1.07 -1.01
Quarter Ending Jun-19 9 -0.91 -0.80 -1.01 -0.95
Year Ending Dec-19 10 -3.70 -3.33 -4.15 -3.84
Year Ending Dec-20 9 -3.41 -2.42 -4.45 -2.95

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 1.30 0.49 0.82 62.63
Quarter Ending Sep-18 0.37 2.36 1.99 536.66
Quarter Ending Jun-18 0.51 0.69 0.17 33.46
Quarter Ending Mar-18 5.07 0.19 4.87 96.19
Quarter Ending Dec-17 0.08 0.04 0.04 50.67
Earnings (per share)
Quarter Ending Dec-18 -0.94 -1.12 0.18 -18.87
Quarter Ending Sep-18 -0.97 -0.91 0.06 -6.02
Quarter Ending Jun-18 -0.94 -0.94 0.00 -0.35
Quarter Ending Mar-18 -0.71 -0.97 0.26 -36.20
Quarter Ending Dec-17 -0.97 -1.14 0.17 -17.18

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 1.84 1.76 1.85 1.21 0.09
Quarter Ending Jun-19 1.83 1.75 1.82 1.16 0.09
Year Ending Dec-19 6.50 6.27 6.24 4.90 0.56
Year Ending Dec-20 40.97 44.57 47.36 55.39 56.26
Earnings (per share)
Quarter Ending Mar-19 -0.90 -0.89 -0.83 -0.97 -1.01
Quarter Ending Jun-19 -0.91 -0.89 -0.82 -0.92 -0.95
Year Ending Dec-19 -3.70 -3.70 -3.55 -3.83 -3.84
Year Ending Dec-20 -3.41 -3.41 -3.27 -3.45 -2.95

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 0 0
Quarter Ending Jun-19 0 0 0 0
Year Ending Dec-19 0 0 1 1
Year Ending Dec-20 0 0 0 1
Earnings
Quarter Ending Mar-19 0 0 0 5
Quarter Ending Jun-19 0 0 0 5
Year Ending Dec-19 0 0 2 7
Year Ending Dec-20 0 0 3 4